Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT05672199 · TERMINATED
Trial details
- NCT number
- NCT05672199
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-28
- Primary completion
- 2024-10-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.